HI

HIGH TECH PHARM CO.,LTD.

Global manufacturer of carbapenem antibiotic APIs for regulated markets.

106190 | KO

Overview

Corporate Details

ISIN(s):
KR7106190002
LEI:
Country:
South Korea
Address:
충청북도 충주시 대소원면 첨단산업6로 12 (주)하이텍팜, 충주시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

HIGH TECH PHARM CO., LTD. is a global pharmaceutical company specializing in the manufacturing of active pharmaceutical ingredients (APIs), with a primary focus on carbapenem-based antibiotic raw materials for injections. The company is a key global supplier, exporting over 95% of its products to more than 40 countries, including the highly regulated markets of the United States, Europe, and Japan. Its state-of-the-art production facilities are designed to meet stringent international standards, such as those from the US FDA and European EDQM, underscoring a commitment to its quality-first policy. Established in 1998, High Tech Pharm leverages its accumulated technology to maintain a competitive position in the worldwide drug substance market.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-09 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.1 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 722.3 KB
2025-05-26 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 708.0 KB
2025-03-24 00:00
Notice of Dividend Amount
[기재정정]현금ㆍ현물배당결정
Korean 12.1 KB
2025-03-21 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 26.6 KB
2025-03-13 00:00
Audit Report / Information
감사보고서제출
Korean 19.0 KB
2025-03-13 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 390.7 KB
2025-03-07 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집공고
Korean 123.4 KB
2025-03-06 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 115.0 KB
2025-02-24 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 13.5 KB
2025-02-24 00:00
Pre-Annual General Meeting Information
주주총회집중일개최사유신고
Korean 4.9 KB
2025-02-06 00:00
Notice of Dividend Amount
현금ㆍ현물배당결정
Korean 9.0 KB
2025-02-06 00:00
Earnings Release
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 11.3 KB
2024-12-16 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.3 KB

Automate Your Workflow. Get a real-time feed of all HIGH TECH PHARM CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for HIGH TECH PHARM CO.,LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for HIGH TECH PHARM CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Apellis Pharmaceuticals, Inc. Logo
Developing novel C3 therapies for diseases in ophthalmology, nephrology, and hematology.
United States of America
APLS
Apimeds Pharmaceuticals US, Inc. Logo
Biopharma developing non-narcotic bee venom therapies for osteoarthritis pain and inflammation.
United States of America
APUS
Apogee Therapeutics, Inc. Logo
Developing novel antibody biologics for immunological and inflammatory (I&I) diseases.
United States of America
APGE
Apollomics Inc. Logo
A clinical-stage biopharma developing targeted oncology therapies for hard-to-treat cancers.
United States of America
APLM
Apontis Pharma AG Logo
German pharma firm specializing in Single Pills for cardiovascular and chronic diseases.
Germany
APPH
Develops DNA tech for genetic medicine, molecular diagnostics, and supply chain security.
United States of America
APDN
Applied Therapeutics, Inc. Logo
Develops treatments for rare metabolic and central nervous system (CNS) disorders.
United States of America
APLT
Aprea Therapeutics, Inc. Logo
Developing precision cancer therapies targeting DNA Damage Response for solid tumors.
United States of America
APRE
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases and oncology using its SAFA™ platform.
South Korea
397030
Aprogen Biologics Inc. Logo
Develops and manufactures novel biologic drugs and biosimilars for the professional market.
South Korea
003060

Talk to a Data Expert

Have a question? We'll get back to you promptly.